Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Novo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche’s latest obesity drug candidate…
Read More
Reviews
0 %
User Score
Rate This
Sharing
Subscribe
Login
0 Comments
Oldest